HLS
Healius Ltd
$0.5800
▲ +0.87%
Market cap
$421M
Turnover
$6,914,148
Last price
$0.5800
Day change
+0.87%
Announcements
8
Range, past year
Open 0.905 · Low 0.300 · Now 0.580 · High 1.635
Open HLS in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
HLS momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
42/100
Wyckoff phase
Accumulation19d
Trend stage
Emerging
1 Day
+0.9%
1 Week
+11.5%
1 Month
+54.7%
1 Year
-34.8%
RSI
81
Avg daily range
4.6%
Healius Ltd scores 42 out of 100 for momentum quality, a reading rated low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Emerging.
On the Wyckoff cycle it sits in Accumulation, where it has been for 19 trading days. The weekly timeframe reads Accumulation, which agrees with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- Fresh trend age (18 days)
Points to watch
- RSI overbought (81) — pullback risk
- 60d drawdown -22.6%
- Risk rating: High
- Composite downside risk elevated
HLS announcements
Recent price-sensitive releases.
- 2026-09-25 Agreement to sell Agilex Biolabs to Novotech Asset Disposal | Trading Halt Lifted | Progress Report
- 2026-09-24 Trading Halt Trading Halt
- 2026-08-19 FY26 Results Presentation Company Presentation | Preliminary Final Report
- 2026-08-19 FY26 Results Release Web Cast | Preliminary Final Report
- 2026-08-19 FY26 Preliminary Final Report Preliminary Final Report
- 2026-06-26 Healius transitions pathology arrangements with Ramsay
- 2026-05-13 FY26 trading update and strategic review of assets
More Health Care stocks
Most traded in the same sector.